With our pivotal ORIGIN 3 trial of atacicept in IgAN on track to announce topline results in the second quarter of 2025 and planned BLA submission to the FDA anticipated later in the year, pending ...
When Dodell-Feder tested this vacuum, it was a pricey $179 — now, at 45% off, it's down to what appears to be its best price of 2024. Oh, and you can snag batteries and a charger for nearly 60% off as ...